Medical News

RSS

Titan Spine's Endoskeleton lumbar interbody fusion devices receive European CE Mark Certification

Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has received CE Mark Certification to commercially release its line of Endoskeleton® lumbar interbody fusion devices in Europe.

5 Apr 2011

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.

5 Apr 2011

New risk calculator predicts risk of postoperative complications for bariatric surgery patients

A new risk calculator can predict the risk of postoperative complications occurring for individual bariatric surgery patients, according to a study published in the March issue of the Journal of the American College of Surgeons. The risk calculator will help in surgical decision-making and will help patients better understand what they can expect during recovery in order to prepare for a bariatric operation.

5 Apr 2011

Post-infection treatment with NanoViricides FluCide reduces lung lesions caused by lethal influenza infection

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide™ drug candidates resulted in dramatic reduction in the number of lung lesions that are caused by a lethal influenza virus infection. These findings were seen in the most recent H1N1 influenza animal study.

5 Apr 2011

Single-incision gall bladder surgery as safe and effective as standard multi-port cholecystectomy

Covidien, a leading global provider of healthcare products, today announced interim results of its multicenter, international, prospective SILS™ Port laparoscopic cholecystectomy (removal of the gall bladder) post-market clinical study.

5 Apr 2011

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

ARIAD Pharmaceuticals, Inc. today announced results of preclinical studies on ponatinib, its investigational pan-BCR-ABL inhibitor, showing potent inhibition of all four members of the fibroblast growth factor receptor (FGFR) family of tyrosine kinases that are abnormally expressed in multiple cancers. ARIAD scientists are presenting the data this morning at the American Association for Cancer Research (AACR) Annual Meeting in Orlando, Florida.

5 Apr 2011

Milliman Care Guidelines presents Doyle Award to ADVANTAGE Health Solutions and Sound Physicians

Milliman Care Guidelines today presented its Doyle Award for Innovation and Leadership in Healthcare to ADVANTAGE Health Solutions, Inc.(SM) and to Sound Physicians. The awards were presented in ceremonies here at the Milliman Care Guidelines Client Forum.

5 Apr 2011

Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two private insurance payers have elected to cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder (OAB) and associated symptoms.

5 Apr 2011

Certified asthma and allergy friendly bedding in hotel rooms

Whether traveling for business or pleasure, the growing population of people with asthma and allergies now has a luxury hotel option that features Certified asthma & allergy friendly® bedding in every room when visiting the Boston area. The Lenox Hotel in the historic Back Bay now features all natural SmartSilk™ silk-filled bedding that has been certified by the Asthma and Allergy Foundation of America (AAFA).

5 Apr 2011

Viking 3D/HD Laparoscopic Vision System provides superior stereoscopic depth perception

Viking Systems, Inc., a leading worldwide developer, manufacturer and marketer of 3D and 2D visualization solutions for complex minimally invasive surgery, announced the results of a poster presentation that was given at the 2011 Society of American Gastrointestinal and Endoscopic Surgeons ("SAGES") meeting held in San Antonio, on April 2, 2011.

5 Apr 2011

AlwaysCare implements Plexis Healthcare Systems' Quantum Choice claims processing software

AlwaysCare Benefits, Inc., one of the country's fastest-growing insurance providers, announced the successful implementation of Plexis Healthcare Systems' Quantum Choice claims processing software to enhance efficient administration of vision benefits on behalf of its insured Members and dependents and its rapidly growing national network of vision care Providers.

5 Apr 2011

R&D Directions names Novavax VLP influenza vaccine as one of top '100 great investigational drugs in development'

Novavax, Inc. announced that its virus-like particle (VLP) influenza vaccine has been named by the editors of R&D Directions magazine as one of the top "100 great investigational drugs in development" today. In its tenth annual list of promising clinical compounds, R&D Directions cited Novavax's virus-like-particle technology as a promising new approach to producing vaccines to prevent seasonal, H1N1 and avian influenza. The list reflects the current interests of industry observers and analysts and is described in the magazine's March 2011 issue.

5 Apr 2011

CAPP introduces new initiative on accountable care for public

The Council of Accountable Physician Practices, an affiliate of the American Medical Group Association, today announced a new initiative to provide the public, media, and policymakers with resources and information about the value of care coordination and accountable care to national health care reform.

5 Apr 2011

La Jolla acquires GliaMed's novel class of compounds

La Jolla Pharmaceutical Company today announced that it has acquired the rights to a novel class of compounds known as Regenerative Immunophilin Ligands from privately held GliaMed, Inc.

5 Apr 2011

Scripted engages CW Rainmakers for Genmed awareness campaign

Genmed Holding Corp. is pleased to announce Scripted Consulting has engaged the services of CW Rainmakers (CW) as an integral part of Scripted's company awareness campaign presently underway for Genmed. Scripted and CW are taking the lead in spreading the word about GENM and its unique, competitive advantages in the generic drug industry.

5 Apr 2011

Court grants motion to dismiss Cryo-Cell International lawsuit against Cord Blood America

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that the Pinellas County Circuit Court granted a motion to dismiss the lawsuit filed by Cryo-Cell International against Cord Blood America, which CBAI management believed was an attempt to inhibit the pending deal between Cryo-Cell Mexico and CBAI.

5 Apr 2011

Majority of customers highly satisfied with neighborhood independent drugstores

New drugstore Ratings published in the May issue of Consumer Reports and available online at www.ConsumerReportsHealth.org reveal that the overwhelming majority (94%) of readers are highly satisfied with their experiences at neighborhood independent drugstores. While customers said they were generally satisfied with their pharmacies, some were irked by long waits and lagging service at some big box stores.

5 Apr 2011

South Sudan health workers face worst Kala-azar outbreak

South Sudan is facing the worst outbreak of Kala-azar in the past 10 years as health workers from Servant's Heart Relief race against the clock to stop the spread of the deadly disease.

5 Apr 2011

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.

5 Apr 2011

NIPH study finds NDMA as one of the most carcinogenic compounds formed during CO2 capture

CO2 capture by means of amines is considered to be the most appropriate method to quickly begin with CO2 removal. During this capture process, some of the amines escaping the recycling process will be emitted into the air and will also form other compounds such as nitrosamines and nitramines.

5 Apr 2011

Medical News

Titan Spine's Endoskeleton lumbar interbody fusion devices receive European CE Mark Certification

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

New risk calculator predicts risk of postoperative complications for bariatric surgery patients

Post-infection treatment with NanoViricides FluCide reduces lung lesions caused by lethal influenza infection

Single-incision gall bladder surgery as safe and effective as standard multi-port cholecystectomy

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

Milliman Care Guidelines presents Doyle Award to ADVANTAGE Health Solutions and Sound Physicians

Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

Certified asthma and allergy friendly bedding in hotel rooms

Viking 3D/HD Laparoscopic Vision System provides superior stereoscopic depth perception

AlwaysCare implements Plexis Healthcare Systems' Quantum Choice claims processing software

R&D Directions names Novavax VLP influenza vaccine as one of top '100 great investigational drugs in development'

CAPP introduces new initiative on accountable care for public

La Jolla acquires GliaMed's novel class of compounds

Scripted engages CW Rainmakers for Genmed awareness campaign

Court grants motion to dismiss Cryo-Cell International lawsuit against Cord Blood America

Majority of customers highly satisfied with neighborhood independent drugstores

South Sudan health workers face worst Kala-azar outbreak

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

NIPH study finds NDMA as one of the most carcinogenic compounds formed during CO2 capture

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News